H-Arg(Pmc)-OH

H-Arg(Pmc)-OH is a protected L-arginine derivative in which the α-amino group is present as the free amino acid hydrochloride-free form (H-), while the guanidino side chain is masked as a Pmc (2,2,5,7,8-pentamethylchroman-6-sulfonyl) carbamate-type protecting group. The molecule retains the stereogenic α-carbon typical of L-arginine, and it presents a carboxylic acid suitable for peptide coupling while the side-chain guanidine is rendered non-basic and less nucleophilic by the bulky, acid-stable Pmc group. The combination of a reactive α-carboxyl group with a protected guanidino functionality supports controlled deprotection strategies during stepwise synthesis. The resulting reactivity profile makes H-Arg(Pmc)-OH a practical chiral amino acid intermediate for protected amino acid chemistry and downstream peptide and conjugate construction.

1. Peptide Synthesis

H-Arg(Pmc)-OH is used in peptide synthesis workflows where arginine incorporation requires side-chain protection compatible with standard coupling and orthogonal deprotection. The α-carboxylic acid enables amide bond formation at the growing peptide chain, while the Pmc-protected guanidine suppresses undesired side reactions and minimizes salt formation during activation and coupling. The stereochemically defined L-α-center supports incorporation into peptides with predictable backbone geometry, and the Pmc group can be removed under conditions that preserve other protecting groups when orthogonal schemes are selected. The resulting arginine residue after deprotection provides a cationic guanidinium for salt-bridge formation and receptor/biomolecule recognition in peptide analogs and protein fragments. H-Arg(Pmc)-OH therefore functions as a protected arginine building block for constructing arginine-rich sequences and for preparing peptide libraries used in biochemical research and structure-activity relationship studies.

2. Bioconjugation Chemistry

H-Arg(Pmc)-OH supports bioconjugation and chemical biology applications requiring controlled introduction of arginine-like cationic sites without premature guanidino reactivity. The carboxylic acid and protected side chain enable stepwise conversion into activated amino acid derivatives or peptide handles while the Pmc group limits guanidine-driven side reactions during conjugation setup. L-arginine stereochemistry and the guanidinium functionality revealed after deprotection can be used to tune binding interactions with nucleic acids, proteins, or cell-surface components in labeling and affinity reagents. The Pmc-protected intermediate can be incorporated into short peptides or linkers that later undergo deprotection to generate a defined positive charge distribution. H-Arg(Pmc)-OH thus serves as a chiral precursor for downstream conjugate synthesis where orthogonality between coupling chemistry and guanidino activation is required.

3. Side-Chain Functionalization

H-Arg(Pmc)-OH is applied in side-chain functionalization strategies that convert arginine into chemically defined derivatives for molecular recognition studies and synthetic methodology development. The Pmc-protected guanidine can be carried through multiple transformations as a masked functional group, allowing selective manipulation of the α-carboxyl group and peptide-compatible derivatization steps. Deprotection yields the free guanidinium, which can then be used for further derivatization, including formation of ionic complexes or incorporation into peptidomimetics that rely on guanidinium-mediated interactions. The chiral amino acid framework provides a stereochemically consistent scaffold for generating analogs that probe how arginine geometry and charge contribute to binding and activity in SAR investigations. H-Arg(Pmc)-OH therefore functions as an intermediate enabling controlled generation of arginine-bearing motifs for fine chemical synthesis and applied molecular design.

4. Protected Amino Acid Chemistry

H-Arg(Pmc)-OH is suitable for protected amino acid synthesis planning where orthogonal protecting-group behavior is required for multi-step manufacturing or library production. The Pmc group serves as a side-chain protecting strategy that stabilizes the guanidino functionality against undesired nucleophilicity during peptide coupling chemistry and intermediate isolation. The presence of the α-carboxylic acid supports conversion to activated esters or coupling partners, while the protected guanidine reduces complications associated with strongly basic species in process-relevant solvent systems. The stereodefined L-configuration aligns with chiral building block requirements for producing enantiopure peptide fragments and research intermediates. H-Arg(Pmc)-OH thereby supports route design for protected amino acid chemistry, including scalable intermediate preparation for fine chemical synthesis and specialty chemical production.

5. Pharmaceutical Manufacturing

H-Arg(Pmc)-OH can be employed in pharmaceutical manufacturing contexts for producing protected arginine-containing peptide intermediates used in process development and quality-controlled synthesis of peptide-based active ingredients or excipients. The α-carboxyl group enables incorporation into peptide sequences under controlled coupling conditions, while the Pmc-protected guanidine helps manage basicity and side reactions during manufacturing-scale intermediate handling. Orthogonal deprotection of the Pmc group supports stepwise generation of the free guanidinium at a defined stage, which can be integrated into manufacturing workflows that require predictable impurity profiles and controlled functional group presentation. The chiral amino acid nature of the starting material supports stereochemical fidelity across the synthetic chain, reducing variability in downstream peptide properties. H-Arg(Pmc)-OH is therefore relevant as a robust protected amino acid intermediate for industrial peptide construction and for supplying defined building blocks to downstream formulation and analytical characterization workflows.

1. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die